Retraction: Metformin attenuates osteoclast-mediated abnormal subchondral bone remodeling and alleviates osteoarthritis via AMPK/NF-κB/ERK signaling pathway

PLoS ONE 2026 Open access

Read full text
Authors: The PLOS One Editors
DOI: 10.1371/journal.pone.0340042
Cited by: 0
References: 2

Abstract

Metformin attenuates osteoclast-mediated abnormal subchondral bone remodeling and alleviates osteoarthritis via AMPK

Fields of Study & Subjects

Bone Metabolism and Diseases Metabolism Diabetes and Cancer Bone health and osteoporosis research

Publication details

Journal / source
PLoS ONE
Volume
21
Issue
1
Pages
e0340042–e0340042
Publication date
8 January 2026
Language
EN